mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |